Daewon Pharmaceutical Presents Oral Diabetes and Obesity Drug Research in US; Plans to File for Phase 1 in Korea Next Year
Predicted impact: Low
Early-stage US research presentation for an oral diabetes drug; no revenue impact yet.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.